Pfizer CEO Albert Bourla about decision to use mRNA vaccine technology

July 27, 2022
Source: www.youtube.com/watch?v=L3c7fTJVrXo

https://www.conference-board.org/events/CED-Distinguished-Leadership-Awards-Dinner

“Nothing of what was accomplished would have been accomplished without partnerships. In our case, we had to partner with BioNTech…But, we also had to partner with the FDA, and the CDC. […] Without their active collaboration—without [our] active sensing of the way that they worked as well—we wouldn't be able to achieve what we achieved.” So says Dr. Albert Bourla, Chairman and CEO, Pfizer, Inc. in this interview with Dr. Lori Esposito Murray, President of the Committee for Economic Development, the public policy center of The Conference Board (CED).

The CED discussion series, Leadership in Challenging Times, interviews business leaders about the unprecedented challenges facing the nation and how they are helping chart a path forward for both their companies and communities in which they operate. Listen as Dr. Bourla tells Dr. Murray about how Pfizer went about making the “impossible possible” with the development and rollout of the mRNA vaccine, as well as Pfizer’s current efforts to extend health equity to all.